The PREDiCT: Imaging Modalities For Oncology Drug Development Summit is dedicated to the strategy, preclinical and clinical stages behind multimodal imaging techniques and applications to enhance therapeutic success.
The PREDiCT: Imaging Modalities For Oncology Drug Development Summit covers topics such as:
- Incorporating machine learning tools in digital pathology
- The benefits behind the trend driving industry in-house imaging modalities to bridge preclinical and clinical research
- Multimodal imaging as hard evidence to indicate therapeutic response and define clinical trial endpoints
- The latest imaging modalities to enhance your understanding of the tumor microenvironment to improve targeted drug response
